ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987